ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,473.23
0.77%
Dow Jones
38,778.10
0.00%
US Dollar vs MXN
18.46225
-0.40%
Brent Oil
83.70
-0.24%
Bitcoin
65,360.71
-1.69%
Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Longeveron Inc (LGVNR)

  7. Longeveron Inc (LGVNR) Noticias

LGVNR Longeveron Inc

0.0005
0.00 (0.00%)
Pre Mercado
Última actualización: 19:00:00
Retrasado por 15 minutos
Nombre Right Símbolo Right Bolsa de Valores Tipo de Valor
Longeveron Inc LGVNR NASDAQ Derecho
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
0.00 0.00% 0.0005 19:00:00
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
0.0005
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
17/6/202408:00GLOBELongeveron® to Present at the Virtual Life Sciences Investor..
17/6/202407:38GLOBELongeveron Announces Exercise of Warrants for $4.4 Million..
11/6/202408:00GLOBELongeveron® Announces Completion of Successful Investigator..
07/6/202417:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/6/202408:00GLOBELongeveron® Announces Contract Development and Manufacturing..
28/5/202407:05GLOBELongeveron® to Attend BIO International Convention 2024
22/5/202416:28EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
21/5/202415:09EDGAR2Form S-1/A - General form for registration of securities..
20/5/202415:19EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
20/5/202415:18EDGAR2Form DEF 14A - Other definitive proxy statements
20/5/202415:09EDGAR2Form ARS - Annual Report to Security Holders
14/5/202415:05GLOBELongeveron Announces First Quarter 2024 Financial Results..
14/5/202415:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/5/202415:30EDGAR2Form 8-K - Current report
10/5/202415:05GLOBELongeveron Announces Board of Directors Planned Transitions
06/5/202417:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/5/202417:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/5/202407:03GLOBELongeveron to Report First Quarter 2024 Financial Results..
25/4/202415:05GLOBELongeveron to Present at the Planet MicroCap Showcase
18/4/202415:30EDGAR2Form 8-K - Current report
18/4/202415:05GLOBELongeveron Raises a Total of $11.4 Million in Gross Proceeds..
17/4/202416:07EDGAR2Form 424B4 - Prospectus [Rule 424(b)(4)]
17/4/202407:00GLOBELongeveron Announces Exercise of Warrants for $6.2 Million..
16/4/202416:02EDGAR2Form S-1/A - General form for registration of securities..
15/4/202407:30GLOBELongeveron’s CLEAR MIND Randomized Phase 2a Clinical Trial..
12/4/202418:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/4/202418:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/4/202416:17GLOBELongeveron Announces Closing of $5.2 Million Public Offering
11/4/202416:10EDGAR2Form 8-K - Current report
10/4/202409:47EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
10/4/202406:48EDGAR2Form 424B4 - Prospectus [Rule 424(b)(4)]
08/4/202413:15GLOBELongeveron Announces Pricing of $5.25 Million Public..
08/4/202407:45EDGAR2Form FWP - Filing under Securities Act Rules 163/433 of free..
08/4/202407:30GLOBELongeveron Issues Letter to Shareholders Highlighting..
05/4/202416:15EDGAR2Form S-1/A - General form for registration of securities..
03/4/202416:20EDGAR2Form S-1/A - General form for registration of securities..
20/3/202416:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/3/202416:14EDGAR2Form S-1 - General form for registration of securities under..
19/3/202415:01EDGAR2Form 8-K - Current report
11/3/202415:01EDGAR2Form 10-K/A - Annual report [Section 13 and 15(d), not S-K..
27/2/202415:05EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
22/2/202415:01EDGAR2Form 8-K - Current report
05/2/202415:50EDGAR2Form DEF 14A - Other definitive proxy statements
02/2/202419:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/1/202415:05EDGAR2Form S-1 - General form for registration of securities under..
25/1/202417:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/1/202417:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/1/202417:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/1/202417:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/1/202416:16EDGAR2Form PRE 14A - Other preliminary proxy statements

Su Consulta Reciente

NASDAQ
LGVNR
Longeveron
LSE
EN22
Citi Fun 25
LSE
SLN
Silence Therapeutics
BIT
P1LSX2
BNP Paribas Issuance
COIN
AXISTUSD
AXIS Token
UNSW3
LORBETH
Leviathan Lobster Token
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados